Updated Jul 16, 2026
Thoren Natasha Fay is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Natasha Fay Thoren is the Chief Legal Officer at X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing therapies for rare immune diseases. She has been involved in the company's legal and regulatory affairs, contributing to its mission of advancing novel therapeutics.
| Role | Chief Legal Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-05-20 | XFOR | X4 Pharmaceuticals, Inc | A — Grant or award | 3.3K | $0.00 |
Natasha Fay Thoren is the Chief Legal Officer at X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing therapies for rare immune diseases. She has been involved in the company's legal and regulatory affairs, contributing to its mission of advancing novel therapeutics.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Thoren Natasha Fay profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.